Replies to post #26542 on OncoSec Medical Inc (ONCSQ)

[Xrouter]

Agree lasers, I've been in bios over 20 years and I just stated my opinion in my post. I respect others opinions and everyone has a right to speculate theirs. If or when The trial shows a better response , ONCS could be grabbed by Merck in a heartbeat for at least 6 billion or around $20 per shAre.. It's my opinion and I don't believe it's so far fetched, I was surprised on the gentle attacks from board members , especially. Furby. Merck may want to react on phase 2 results and before ONCS reaches Phase 3 .. Putting the puzzle together with X Merck personnel in Oncs, the legal staff being hired as well as new hires at strategic positions. This screams buyout ( In MyOpinion). Good luck all,Strik

[trading.jeff]

If the results show that the Combo has a higher healing rate, then there is no limit to $ONCS PPS.

Actually, lasers, there would be a limit to $ONCS's pps. It's called the sky and Punit would be next to a fool if he didn't play this card in any possible buyout negotiations. At the same time, I don't think any big pharma company would write a blank check for OncoSec. There would be negotiations to set a buyout price.

We do need to remember that Punit is driving this bus and has OncoSec exactly where it needs to be at this point in time.

JMHO.

$ONCS